VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q72206056  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000209.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q72206056‏
035 ‎‡a  (OCoLC)Q72206056‏
043 ‎‡c  US‏
046 ‎‡f  19471115‏
100 0 ‎‡a  Janet B. W. Williams‏ ‎‡c  American social worker‏ ‎‡9  en‏
375 ‎‡a  2‏ ‎‡2  iso5218‏
400 0 ‎‡a  Janet B. W. Williams‏ ‎‡c  Amerikaans maatschappelijk werkster‏ ‎‡9  nl‏
400 0 ‎‡a  Janet B. W. Williams‏ ‎‡c  asistenta social estauxunidense‏ ‎‡9  ast‏
400 0 ‎‡a  재닛 B. W. 윌리엄스‏ ‎‡c  미국 사회복지사‏ ‎‡9  ko‏
670 ‎‡a  Author's A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia‏
670 ‎‡a  Author's A brief measure for assessing generalized anxiety disorder: the GAD-7.‏
670 ‎‡a  Author's A comparison of face-to-face and remote assessment of inter-rater reliability on the Hamilton Depression Rating Scale via videoconferencing‏
670 ‎‡a  Author's A field trial of DSM-III-R psychoactive substance dependence disorders‏
670 ‎‡a  Author's A new approach to rater training and certification in a multicenter clinical trial‏
670 ‎‡a  Author's A novel approach to rater training and certification in multinational trials.‏
670 ‎‡a  Author's A proposal for DSM-IV: solving the "organic/nonorganic" problem.‏
670 ‎‡a  Author's A structured diagnostic interview for hypochondriasis. A proposed criterion standard‏
670 ‎‡a  Author's American psychiatry's transformation following the publication of DSM-III.‏
670 ‎‡a  Author's An empirical study of the issue of sex bias in the diagnostic criteria of DSM-III axis II personality disorders.‏
670 ‎‡a  Author's An ultra-brief screening scale for anxiety and depression: the PHQ-4.‏
670 ‎‡a  Author's Another perspective on "putting DSM-IV in perspective"‏
670 ‎‡a  Author's Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.‏
670 ‎‡a  Author's Are the effects of rater training sustainable? Results from a multicenter clinical trial‏
670 ‎‡a  Author's Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians‏
670 ‎‡a  Author's Clinical utility as a criterion for revising psychiatric diagnoses‏
670 ‎‡a  Author's Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder‏
670 ‎‡a  Author's Consistency checks to improve measurement with the Montgomery-Asberg Depression Rating Scale (MADRS)‏
670 ‎‡a  Author's Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment‏
670 ‎‡a  Author's Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale‏
670 ‎‡a  Author's Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).‏
670 ‎‡a  Author's Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire‏
670 ‎‡a  Author's Differing symptoms of abused versus nonabused women in obstetric-gynecology settings.‏
670 ‎‡a  Author's DSM-III in residency training: results of a national survey‏
670 ‎‡a  Author's DSM-III-R criteria for posttraumatic stress disorder‏
670 ‎‡a  Author's DSM-III: the major achievements and an overview‏
670 ‎‡a  Author's DTREE: An Expert System for Psychiatric Diagnosis‏
670 ‎‡a  Author's DTREE: Microcomputer-Assisted Teaching of Psychiatric Diagnosis Using a Decision Tree Model‏
670 ‎‡a  Author's Effects of structured interview guides and rater monitoring in clinical trials‏
670 ‎‡a  Author's Face-to-face versus remote administration of the Montgomery-Asberg Depression Rating Scale using videoconference and telephone.‏
670 ‎‡a  Author's Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety‏
670 ‎‡a  Author's Having a dream. A research strategy for DSM-IV.‏
670 ‎‡a  Author's Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients‏
670 ‎‡a  Author's Hysteroid dysphoria: an unsuccessful attempt to demonstrate its syndromal validity‏
670 ‎‡a  Author's Identifying patients with depression in the primary care setting: a more efficient method‏
670 ‎‡a  Author's idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder‏
670 ‎‡a  Author's International reliability of a diagnostic intake procedure for panic disorder‏
670 ‎‡a  Author's Ischemic stroke and depression‏
670 ‎‡a  Author's Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial‏
670 ‎‡a  Author's Late luteal phase dysphoric disorder and DSM-III-R‏
670 ‎‡a  Author's Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care‏
670 ‎‡a  Author's National field trial of the DSM-III-R diagnostic criteria for self-defeating personality disorder‏
670 ‎‡a  Author's Now is the time to retire the term "organic mental disorders"‏
670 ‎‡a  Author's Primary care patients in psychiatric clinical trials: a pilot study using videoconferencing‏
670 ‎‡a  Author's Proposed changes in DSM-III substance use disorders: description and rationale‏
670 ‎‡a  Author's Psychiatric diagnosis.‏
670 ‎‡a  Author's Psychodynamic perspective on DSM-III.‏
670 ‎‡a  Author's Psychological disorders and distress in older primary care patients: a comparison of older and younger samples.‏
670 ‎‡a  Author's Psychotic disorders in DSM-III-R.‏
670 ‎‡a  Author's Rater training in multicenter clinical trials: issues and recommendations‏
670 ‎‡a  Author's Reliability in the DSM-III field trials: interview v case summary.‏
670 ‎‡a  Author's Research diagnostic criteria and DSM-III: an annotated comparison‏
670 ‎‡a  Author's Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorders‏
670 ‎‡a  Author's Scaled ratings of DSM-III personality disorders‏
670 ‎‡a  Author's Self-defeating personality disorder and DSM-III-R: development of the diagnostic criteria‏
670 ‎‡a  Author's Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response‏
670 ‎‡a  Author's Sources of unreliability in depression ratings‏
670 ‎‡a  Author's Standards for DSM-5 reliability‏
670 ‎‡a  Author's Supervising intake diagnosis. A psychiatric 'Rashomon'.‏
670 ‎‡a  Author's Teaching and learning DSM-III‏
670 ‎‡a  Author's The dependence syndrome across different psychoactive substances: revised DSM-III.‏
670 ‎‡a  Author's The DSK-III Classification of Affective Disorders.‏
670 ‎‡a  Author's The DSM-III classification of affective disorders‏
670 ‎‡a  Author's The DSM-III-R personality disorders: an overview‏
670 ‎‡a  Author's The factor structure of self-report DSM-III axis II symptoms and their relationship to clinicians' ratings‏
670 ‎‡a  Author's The GRID-HAMD: standardization of the Hamilton Depression Rating Scale‏
670 ‎‡a  Author's The issue of sex bias in DSM-III. A critique of "A Woman's View of DSM-III" by Marcie Kaplan.‏
670 ‎‡a  Author's The MCMI and DSM-III: a brief rejoinder to Million (1985)‏
670 ‎‡a  Author's The MCMI as a measure of DSM-III.‏
670 ‎‡a  Author's The Patient Health Questionnaire-2: validity of a two-item depression screener.‏
670 ‎‡a  Author's The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients‏
670 ‎‡a  Author's The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms‏
670 ‎‡a  Author's The PHQ-8 as a measure of current depression in the general population‏
670 ‎‡a  Author's The Structured Clinical Interview for DSM-III-R‏
670 ‎‡a  Author's The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description‏
670 ‎‡a  Author's The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability‏
670 ‎‡a  Author's Transcultural Adaptation of GRID Hamilton Rating Scale For Depression‏
670 ‎‡a  Author's Transcultural Adaptation of GRID Hamilton Rating Scale For Depression (GRID-HAMD) to Brazilian Portuguese and Evaluation of the Impact of Training Upon Inter-Rater Reliability.‏
670 ‎‡a  Author's Trauma exposure and posttraumatic stress disorder in primary care patients: cross-sectional criterion standard study‏
670 ‎‡a  Author's Traumatic brain injury in individuals convicted of sexual offenses with and without bipolar disorder‏
670 ‎‡a  Author's Why the Hamilton Depression Rating Scale Endures‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NII|DA05008112‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NDL|00963987‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/DNB|1145566154‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NUKAT|n 2018280655‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/ISNI|000000008467917X‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NTA|070293694‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/KRNLK|KAC201753938‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NSK|000254437‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/viaf/111476399‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NKC|xx0189288‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/LC|n 83157734‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/SUDOC|10461935X‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NLI|004153103‏
670 ‎‡a  wikidata site links‏ ‎‡u  https://en.wikipedia.org/wiki/Janet_B._W._Williams‏
919 ‎‡a  psychoticdisordersindsm3r‏ ‎‡A  Psychotic disorders in DSM-III-R.‏ ‎‡9  1‏
919 ‎‡a  psychiatricdiagnosis‏ ‎‡A  Psychiatric diagnosis.‏ ‎‡9  1‏
919 ‎‡a  ratertraininginmulticenterclinicaltrialsissuesandrecommendations‏ ‎‡A  Rater training in multicenter clinical trials: issues and recommendations‏ ‎‡9  1‏
919 ‎‡a  proposedchangesindsm3substanceusedisordersdescriptionandrationale‏ ‎‡A  Proposed changes in DSM-III substance use disorders: description and rationale‏ ‎‡9  1‏
919 ‎‡a  primarycarepatientsinpsychiatricclinicaltrialsapilotstudyusingvideoconferencing‏ ‎‡A  Primary care patients in psychiatric clinical trials: a pilot study using videoconferencing‏ ‎‡9  1‏
919 ‎‡a  reliabilityinthedsm3fieldtrialsinterview5casesummary‏ ‎‡A  Reliability in the DSM-III field trials: interview v case summary.‏ ‎‡9  1‏
919 ‎‡a  nationalfieldtrialofthedsm3rdiagnosticcriteriaforselfdefeatingpersonalitydisorder‏ ‎‡A  National field trial of the DSM-III-R diagnostic criteria for self-defeating personality disorder‏ ‎‡9  1‏
919 ‎‡a  multisomatoformdisorderanalternativetoundifferentiatedsomatoformdisorderforthesomatizingpatientinprimarycare‏ ‎‡A  Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care‏ ‎‡9  1‏
919 ‎‡a  latelutealphasedysphoricdisorderanddsm3r‏ ‎‡A  Late luteal phase dysphoric disorder and DSM-III-R‏ ‎‡9  1‏
919 ‎‡a  researchdiagnosticcriteriaanddsm3anannotatedcomparison‏ ‎‡A  Research diagnostic criteria and DSM-III: an annotated comparison‏ ‎‡9  1‏
919 ‎‡a  reviseddiagnosticcriteriaandanewstructuredinterviewfordiagnosinganxietydisorders‏ ‎‡A  Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorders‏ ‎‡9  1‏
919 ‎‡a  jetlagclinicalfeaturesvalidationofanewsyndromespecificscaleandlackofresponsetomelatonininarandomizeddoubleblindtrial‏ ‎‡A  Jet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial‏ ‎‡9  1‏
919 ‎‡a  scaledratingsofdsm3personalitydisorders‏ ‎‡A  Scaled ratings of DSM-III personality disorders‏ ‎‡9  1‏
919 ‎‡a  selfdefeatingpersonalitydisorderanddsm3rdevelopmentofthediagnosticcriteria‏ ‎‡A  Self-defeating personality disorder and DSM-III-R: development of the diagnostic criteria‏ ‎‡9  1‏
919 ‎‡a  siteversuscentralizedratersinaclinicaldepressiontrialimpactonpatientselectionandplaceboresponse‏ ‎‡A  Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response‏ ‎‡9  1‏
919 ‎‡a  ischemicstrokeanddepression‏ ‎‡A  Ischemic stroke and depression‏ ‎‡9  1‏
919 ‎‡a  internationalreliabilityofadiagnosticintakeprocedureforpanicdisorder‏ ‎‡A  International reliability of a diagnostic intake procedure for panic disorder‏ ‎‡9  1‏
919 ‎‡a  idiopathicpaindisorderacritiqueofpainpronedisorderandaproposalforarevisionofthedsm3categorypsychogenicpaindisorder‏ ‎‡A  idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder‏ ‎‡9  1‏
919 ‎‡a  identifyingpatientswithdepressionintheprimarycaresettingamoreefficientmethod‏ ‎‡A  Identifying patients with depression in the primary care setting: a more efficient method‏ ‎‡9  1‏
919 ‎‡a  hysteroiddysphoriaanunsuccessfulattempttodemonstrateitssyndromalvalidity‏ ‎‡A  Hysteroid dysphoria: an unsuccessful attempt to demonstrate its syndromal validity‏ ‎‡9  1‏
919 ‎‡a  sourcesofunreliabilityindepressionratings‏ ‎‡A  Sources of unreliability in depression ratings‏ ‎‡9  1‏
919 ‎‡a  standardsfordsm5reliability‏ ‎‡A  Standards for DSM-5 reliability‏ ‎‡9  1‏
919 ‎‡a  supervisingintakediagnosisapsychiatricrashomon‏ ‎‡A  Supervising intake diagnosis. A psychiatric 'Rashomon'.‏ ‎‡9  1‏
919 ‎‡a  teachingandlearningdsm3‏ ‎‡A  Teaching and learning DSM-III‏ ‎‡9  1‏
919 ‎‡a  dependencesyndromeacrossdifferentpsychoactivesubstancesreviseddsm3‏ ‎‡A  The dependence syndrome across different psychoactive substances: revised DSM-III.‏ ‎‡9  1‏
919 ‎‡a  healthproblemsimpairmentandillnessesassociatedwithbulimianervosaandbingeeatingdisorderamongprimarycareandobstetricgynaecologypatients‏ ‎‡A  Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients‏ ‎‡9  1‏
919 ‎‡a  havingadreamaresearchstrategyfordsm4‏ ‎‡A  Having a dream. A research strategy for DSM-IV.‏ ‎‡9  1‏
919 ‎‡a  gastrointestinalsymptomsinprimarycareprevalenceandassociationwithdepressionandanxiety‏ ‎‡A  Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety‏ ‎‡9  1‏
919 ‎‡a  facetofaceversusremoteadministrationofthemontgomeryasbergdepressionratingscaleusingvideoconferenceandtelephone‏ ‎‡A  Face-to-face versus remote administration of the Montgomery-Asberg Depression Rating Scale using videoconference and telephone.‏ ‎‡9  1‏
919 ‎‡a  effectsofstructuredinterviewguidesandratermonitoringinclinicaltrials‏ ‎‡A  Effects of structured interview guides and rater monitoring in clinical trials‏ ‎‡9  1‏
919 ‎‡a  dsk3classificationofaffectivedisorders‏ ‎‡A  The DSK-III Classification of Affective Disorders.‏ ‎‡9  1‏
919 ‎‡a  dtreemicrocomputerassistedteachingofpsychiatricdiagnosisusingadecisiontreemodel‏ ‎‡A  DTREE: Microcomputer-Assisted Teaching of Psychiatric Diagnosis Using a Decision Tree Model‏ ‎‡9  1‏
919 ‎‡a  dtreeanexpertsystemforpsychiatricdiagnosis‏ ‎‡A  DTREE: An Expert System for Psychiatric Diagnosis‏ ‎‡9  1‏
919 ‎‡a  dsm3themajorachievementsandanoverview‏ ‎‡A  DSM-III: the major achievements and an overview‏ ‎‡9  1‏
919 ‎‡a  dsm3classificationofaffectivedisorders‏ ‎‡A  The DSM-III classification of affective disorders‏ ‎‡9  1‏
919 ‎‡a  dsm3rcriteriaforposttraumaticstressdisorder‏ ‎‡A  DSM-III-R criteria for posttraumatic stress disorder‏ ‎‡9  1‏
919 ‎‡a  dsm3inresidencytrainingresultsofanationalsurvey‏ ‎‡A  DSM-III in residency training: results of a national survey‏ ‎‡9  1‏
919 ‎‡a  differingsymptomsofabusedversusnonabusedwomeninobstetricgynecologysettings‏ ‎‡A  Differing symptoms of abused versus nonabused women in obstetric-gynecology settings.‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofascreeninginstrumentforbipolarspectrumdisorderthemooddisorderquestionnaire‏ ‎‡A  Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire‏ ‎‡9  1‏
919 ‎‡a  developmentandreliabilityofastructuredinterviewguideforthemontgomeryasbergdepressionratingscalesigma‏ ‎‡A  Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).‏ ‎‡9  1‏
919 ‎‡a  developmentandreliabilityofastructuredinterviewguideforthemontgomeryasbergdepressionratingscale‏ ‎‡A  Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale‏ ‎‡9  1‏
919 ‎‡a  depressionanxietyandsomatizationinprimarycaresyndromeoverlapandfunctionalimpairment‏ ‎‡A  Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment‏ ‎‡9  1‏
919 ‎‡a  dsm3rpersonalitydisordersanoverview‏ ‎‡A  The DSM-III-R personality disorders: an overview‏ ‎‡9  1‏
919 ‎‡a  consistencycheckstoimprovemeasurementwiththemontgomeryasbergdepressionratingscalemadrs‏ ‎‡A  Consistency checks to improve measurement with the Montgomery-Asberg Depression Rating Scale (MADRS)‏ ‎‡9  1‏
919 ‎‡a  comparisonofsitebasedversuscentralratingsinastudyofgeneralizedanxietydisorder‏ ‎‡A  Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder‏ ‎‡9  1‏
919 ‎‡a  clinicalutilityasacriterionforrevisingpsychiatricdiagnoses‏ ‎‡A  Clinical utility as a criterion for revising psychiatric diagnoses‏ ‎‡9  1‏
919 ‎‡a  attitudestowardborderlinepersonalitydisorderasurveyof706mentalhealthclinicians‏ ‎‡A  Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians‏ ‎‡9  1‏
919 ‎‡a  factorstructureofselfreportdsm3axis2symptomsandtheirrelationshiptocliniciansratings‏ ‎‡A  The factor structure of self-report DSM-III axis II symptoms and their relationship to clinicians' ratings‏ ‎‡9  1‏
919 ‎‡a  aretheeffectsofratertrainingsustainableresultsfromamulticenterclinicaltrial‏ ‎‡A  Are the effects of rater training sustainable? Results from a multicenter clinical trial‏ ‎‡9  1‏
919 ‎‡a  anxietydisordersinprimarycareprevalenceimpairmentcomorbidityanddetection‏ ‎‡A  Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.‏ ‎‡9  1‏
919 ‎‡a  gridhamdstandardizationofthehamiltondepressionratingscale‏ ‎‡A  The GRID-HAMD: standardization of the Hamilton Depression Rating Scale‏ ‎‡9  1‏
919 ‎‡a  issueofsexbiasindsm3acritiqueofawomansviewofdsm3bymarciekaplan‏ ‎‡A  The issue of sex bias in DSM-III. A critique of "A Woman's View of DSM-III" by Marcie Kaplan.‏ ‎‡9  1‏
919 ‎‡a  1901anddsm3abriefrejoindertomillion‏ ‎‡A  The MCMI and DSM-III: a brief rejoinder to Million (1985)‏ ‎‡9  1‏
919 ‎‡a  anotherperspectiveonputtingdsm4inperspective‏ ‎‡A  Another perspective on "putting DSM-IV in perspective"‏ ‎‡9  1‏
919 ‎‡a  1901asameasureofdsm3‏ ‎‡A  The MCMI as a measure of DSM-III.‏ ‎‡9  1‏
919 ‎‡a  ultrabriefscreeningscaleforanxietyanddepressionthephq4‏ ‎‡A  An ultra-brief screening scale for anxiety and depression: the PHQ-4.‏ ‎‡9  1‏
919 ‎‡a  empiricalstudyoftheissueofsexbiasinthediagnosticcriteriaofdsm3axis2personalitydisorders‏ ‎‡A  An empirical study of the issue of sex bias in the diagnostic criteria of DSM-III axis II personality disorders.‏ ‎‡9  1‏
919 ‎‡a  patienthealthquestionnaire2validityofa2itemdepressionscreener‏ ‎‡A  The Patient Health Questionnaire-2: validity of a two-item depression screener.‏ ‎‡9  1‏
919 ‎‡a  patienthealthquestionnaireforadolescentsvalidationofaninstrumentfortheassessmentofmentaldisordersamongadolescentprimarycarepatients‏ ‎‡A  The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients‏ ‎‡9  1‏
919 ‎‡a  phq15validityofanewmeasureforevaluatingtheseverityofsomaticsymptoms‏ ‎‡A  The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms‏ ‎‡9  1‏
919 ‎‡a  phq8asameasureofcurrentdepressioninthegeneralpopulation‏ ‎‡A  The PHQ-8 as a measure of current depression in the general population‏ ‎‡9  1‏
919 ‎‡a  structuredclinicalinterviewfordsm3r‏ ‎‡A  The Structured Clinical Interview for DSM-III-R‏ ‎‡9  1‏
919 ‎‡a  structuredclinicalinterviewfordsm3rscid1historyrationaleanddescription‏ ‎‡A  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description‏ ‎‡9  1‏
919 ‎‡a  structuredclinicalinterviewfordsm3rscid2multisitetestretestreliability‏ ‎‡A  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability‏ ‎‡9  1‏
919 ‎‡a  transculturaladaptationofgridhamiltonratingscalefordepression‏ ‎‡A  Transcultural Adaptation of GRID Hamilton Rating Scale For Depression‏ ‎‡9  1‏
919 ‎‡a  transculturaladaptationofgridhamiltonratingscalefordepressiongridhamdtobrazilianportugueseandevaluationoftheimpactoftraininguponinterraterreliability‏ ‎‡A  Transcultural Adaptation of GRID Hamilton Rating Scale For Depression (GRID-HAMD) to Brazilian Portuguese and Evaluation of the Impact of Training Upon Inter-Rater Reliability.‏ ‎‡9  1‏
919 ‎‡a  traumaexposureandposttraumaticstressdisorderinprimarycarepatientscrosssectionalcriterionstandardstudy‏ ‎‡A  Trauma exposure and posttraumatic stress disorder in primary care patients: cross-sectional criterion standard study‏ ‎‡9  1‏
919 ‎‡a  traumaticbraininjuryinindividualsconvictedofsexualoffenseswithandwithoutbipolardisorder‏ ‎‡A  Traumatic brain injury in individuals convicted of sexual offenses with and without bipolar disorder‏ ‎‡9  1‏
919 ‎‡a  whythehamiltondepressionratingscaleendures‏ ‎‡A  Why the Hamilton Depression Rating Scale Endures‏ ‎‡9  1‏
919 ‎‡a  americanpsychiatrystransformationfollowingthepublicationofdsm3‏ ‎‡A  American psychiatry's transformation following the publication of DSM-III.‏ ‎‡9  1‏
919 ‎‡a  structureddiagnosticinterviewforhypochondriasisaproposedcriterionstandard‏ ‎‡A  A structured diagnostic interview for hypochondriasis. A proposed criterion standard‏ ‎‡9  1‏
919 ‎‡a  proposalfordsm4solvingtheorganicnonorganicproblem‏ ‎‡A  A proposal for DSM-IV: solving the "organic/nonorganic" problem.‏ ‎‡9  1‏
919 ‎‡a  novelapproachtoratertrainingandcertificationinmultinationaltrials‏ ‎‡A  A novel approach to rater training and certification in multinational trials.‏ ‎‡9  1‏
919 ‎‡a  newapproachtoratertrainingandcertificationinamulticenterclinicaltrial‏ ‎‡A  A new approach to rater training and certification in a multicenter clinical trial‏ ‎‡9  1‏
919 ‎‡a  fieldtrialofdsm3rpsychoactivesubstancedependencedisorders‏ ‎‡A  A field trial of DSM-III-R psychoactive substance dependence disorders‏ ‎‡9  1‏
919 ‎‡a  comparisonoffacetofaceandremoteassessmentofinterraterreliabilityonthehamiltondepressionratingscaleviavideoconferencing‏ ‎‡A  A comparison of face-to-face and remote assessment of inter-rater reliability on the Hamilton Depression Rating Scale via videoconferencing‏ ‎‡9  1‏
919 ‎‡a  briefmeasureforassessinggeneralizedanxietydisorderthegad7‏ ‎‡A  A brief measure for assessing generalized anxiety disorder: the GAD-7.‏ ‎‡9  1‏
919 ‎‡a  6weekrandomizeddoubleblindplacebocontrolledcomparatorreferencedtrialofvabicaserininacuteschizophrenia‏ ‎‡A  A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia‏ ‎‡9  1‏
919 ‎‡a  nowisthetimetoretirethetermorganicmentaldisorders‏ ‎‡A  Now is the time to retire the term "organic mental disorders"‏ ‎‡9  1‏
919 ‎‡a  psychologicaldisordersanddistressinolderprimarycarepatientsacomparisonofolderandyoungersamples‏ ‎‡A  Psychological disorders and distress in older primary care patients: a comparison of older and younger samples.‏ ‎‡9  1‏
919 ‎‡a  psychodynamicperspectiveondsm3‏ ‎‡A  Psychodynamic perspective on DSM-III.‏ ‎‡9  1‏
943 ‎‡a  198x‏ ‎‡A  1985‏ ‎‡9  1‏
946 ‎‡a  a‏ ‎‡9  1‏
947 ‎‡a  US‏ ‎‡9  1‏
996 ‎‡2  J9U|987012501144705171‏
996 ‎‡2  SUDOC|056911009‏
996 ‎‡2  ISNI|0000000103728791‏
996 ‎‡2  DNB|134844653‏
996 ‎‡2  SUDOC|244971269‏
996 ‎‡2  ISNI|0000000356167144‏
996 ‎‡2  NTA|073625973‏
996 ‎‡2  RERO|A003977181‏
996 ‎‡2  RERO|A003977182‏
996 ‎‡2  SUDOC|029802423‏
996 ‎‡2  RERO|A008963309‏
996 ‎‡2  DNB|1156359597‏
996 ‎‡2  LC|n 80108244‏
996 ‎‡2  ISNI|000000044264180X‏
996 ‎‡2  ISNI|0000000024941332‏
996 ‎‡2  BIBSYS|90267750‏
996 ‎‡2  N6I|vtls001230768‏
996 ‎‡2  SUDOC|243812663‏
996 ‎‡2  CAOONL|ncf12092707‏
996 ‎‡2  BNF|15044555‏
996 ‎‡2  ISNI|0000000497745892‏
996 ‎‡2  DNB|128543868X‏
996 ‎‡2  LC|n 86072817‏
996 ‎‡2  BNF|12928414‏
996 ‎‡2  LC|n 88618804‏
996 ‎‡2  LC|no2024126043‏
996 ‎‡2  BNF|14402650‏
996 ‎‡2  BNF|16627128‏
996 ‎‡2  LC|n 83328300‏
996 ‎‡2  LC|no2002032204‏
996 ‎‡2  LC|no2020109404‏
996 ‎‡2  LC|nb2013025014‏
996 ‎‡2  LC|n 85155046‏
996 ‎‡2  N6I|vtls001294818‏
996 ‎‡2  BNE|XX4922402‏
996 ‎‡2  RERO|A012502885‏
996 ‎‡2  NTA|39409803X‏
996 ‎‡2  ISNI|0000000079561476‏
996 ‎‡2  NTA|135508398‏
996 ‎‡2  LC|n 83157734‏
996 ‎‡2  BNF|16154384‏
996 ‎‡2  J9U|987007526510305171‏
996 ‎‡2  BIBSYS|90713504‏
996 ‎‡2  NTA|073782734‏
996 ‎‡2  BNF|15609338‏
996 ‎‡2  LC|n 94021179‏
996 ‎‡2  NSK|000613546‏
996 ‎‡2  NSK|000737954‏
996 ‎‡2  SUDOC|032116330‏
996 ‎‡2  PLWABN|9810673839305606‏
996 ‎‡2  ISNI|0000000391905560‏
996 ‎‡2  NUKAT|n 2019182544‏
996 ‎‡2  BIBSYS|90813130‏
996 ‎‡2  CAOONL|ncf11242434‏
996 ‎‡2  BIBSYS|90797527‏
996 ‎‡2  RERO|A006533665‏
996 ‎‡2  SUDOC|183049691‏
996 ‎‡2  LC|n 85019617‏
996 ‎‡2  N6I|vtls000019737‏
996 ‎‡2  LC|no 95013227‏
996 ‎‡2  LC|no2009084036‏
996 ‎‡2  J9U|987007422151605171‏
996 ‎‡2  ISNI|0000000123303141‏
996 ‎‡2  LC|n 91093233‏
996 ‎‡2  NUKAT|n 2023167521‏
996 ‎‡2  DNB|1043359370‏
996 ‎‡2  RERO|A003977177‏
996 ‎‡2  RERO|A003977178‏
996 ‎‡2  DNB|136395015‏
996 ‎‡2  NUKAT|n 97014330‏
996 ‎‡2  CAOONL|ncf11389929‏
996 ‎‡2  ISNI|0000000115794366‏
996 ‎‡2  BNF|12375900‏
996 ‎‡2  J9U|987007437565305171‏
996 ‎‡2  NTA|18963278X‏
996 ‎‡2  CAOONL|ncf11634522‏
996 ‎‡2  NII|DA02359631‏
996 ‎‡2  J9U|987007278616505171‏
996 ‎‡2  LC|n 92024441‏
996 ‎‡2  SUDOC|033241457‏
996 ‎‡2  NUKAT|n 2019075705‏
996 ‎‡2  ISNI|0000000384881062‏
996 ‎‡2  BNF|17845427‏
996 ‎‡2  NYNYRILM|256529‏
996 ‎‡2  LC|no2008066696‏
996 ‎‡2  LC|n 79055554‏
996 ‎‡2  LC|no2024073204‏
996 ‎‡2  BNF|12478480‏
996 ‎‡2  ISNI|0000000427976951‏
996 ‎‡2  BIBSYS|90748664‏
996 ‎‡2  LC|nb2010020480‏
996 ‎‡2  ISNI|0000000112976287‏
996 ‎‡2  BNF|12412781‏
996 ‎‡2  CAOONL|ncf11869883‏
996 ‎‡2  ISNI|0000000067466623‏
996 ‎‡2  ISNI|0000000418594978‏
996 ‎‡2  ISNI|0000000022308429‏
996 ‎‡2  NSK|000032413‏
996 ‎‡2  LC|no 95054604‏
996 ‎‡2  BIBSYS|8083397‏
996 ‎‡2  ISNI|0000000395737947‏
996 ‎‡2  N6I|vtls000095065‏
996 ‎‡2  SUDOC|242816460‏
996 ‎‡2  NUKAT|n 2017063436‏
996 ‎‡2  ISNI|0000000451201873‏
996 ‎‡2  ISNI|0000000062940082‏
996 ‎‡2  ISNI|0000000496907079‏
996 ‎‡2  J9U|987012722607905171‏
996 ‎‡2  ISNI|0000000043366425‏
996 ‎‡2  LC|n 82038303‏
996 ‎‡2  NUKAT|n 97025901‏
996 ‎‡2  SUDOC|257674195‏
996 ‎‡2  J9U|987007272064505171‏
996 ‎‡2  ISNI|000000008467917X‏
996 ‎‡2  LC|no 90009946‏
996 ‎‡2  ISNI|0000000040358198‏
996 ‎‡2  NDL|00461012‏
996 ‎‡2  BIBSYS|90579028‏
996 ‎‡2  LC|n 93803389‏
996 ‎‡2  J9U|987007344378905171‏
996 ‎‡2  LC|no 96019894‏
996 ‎‡2  SUDOC|175411344‏
996 ‎‡2  ISNI|0000000032945288‏
996 ‎‡2  CAOONL|ncf11031309‏
996 ‎‡2  J9U|987012501283405171‏
996 ‎‡2  DNB|1338954083‏
996 ‎‡2  LC|no2007045241‏
996 ‎‡2  ISNI|0000000119335095‏
996 ‎‡2  NTA|302990917‏
996 ‎‡2  B2Q|0000288325‏
996 ‎‡2  NDL|00963987‏
996 ‎‡2  ISNI|0000000075932495‏
996 ‎‡2  CAOONL|ncf12092605‏
996 ‎‡2  LC|n 91110245‏
996 ‎‡2  LC|n 83188829‏
996 ‎‡2  NII|DA09479777‏
996 ‎‡2  BLBNB|000386431‏
996 ‎‡2  ISNI|0000000024264001‏
996 ‎‡2  LC|n 85806461‏
996 ‎‡2  RERO|A008631862‏
996 ‎‡2  B2Q|0000831048‏
996 ‎‡2  SUDOC|120562863‏
996 ‎‡2  LC|n 2009181350‏
996 ‎‡2  J9U|987007429194405171‏
996 ‎‡2  LC|n 92047035‏
996 ‎‡2  LC|n 88674082‏
996 ‎‡2  N6I|vtls000288947‏
996 ‎‡2  ISNI|0000000028672520‏
996 ‎‡2  ISNI|000000008294788X‏
996 ‎‡2  SUDOC|20064162X‏
996 ‎‡2  DNB|121189252‏
996 ‎‡2  LC|n 79037963‏
996 ‎‡2  PLWABN|9810590612705606‏
996 ‎‡2  ISNI|0000000081182440‏
996 ‎‡2  ISNI|0000000027692925‏
996 ‎‡2  BNC|981058528602006706‏
996 ‎‡2  J9U|987007434957805171‏
996 ‎‡2  LC|n 85808922‏
996 ‎‡2  NUKAT|n 2003087828‏
996 ‎‡2  LC|n 2018188071‏
996 ‎‡2  DNB|189569689‏
996 ‎‡2  ISNI|0000000409905594‏
996 ‎‡2  SUDOC|255251440‏
996 ‎‡2  SZ|1236919289‏
996 ‎‡2  LC|nr 93049144‏
996 ‎‡2  RERO|A024437837‏
996 ‎‡2  BNCHL|10000000000000000844106‏
996 ‎‡2  NTA|101003218‏
996 ‎‡2  LC|no2022154376‏
996 ‎‡2  RERO|A003977164‏
996 ‎‡2  NII|DA03730247‏
996 ‎‡2  RERO|A003977163‏
996 ‎‡2  BIBSYS|1029519‏
996 ‎‡2  CAOONL|ncf10100270‏
996 ‎‡2  NTA|08722416X‏
996 ‎‡2  BNE|XX1792980‏
996 ‎‡2  SUDOC|157556107‏
996 ‎‡2  DNB|128870613‏
996 ‎‡2  J9U|987007333543505171‏
996 ‎‡2  CAOONL|ncf10952271‏
996 ‎‡2  BIBSYS|1014932‏
996 ‎‡2  BIBSYS|90654764‏
996 ‎‡2  DNB|173391745‏
996 ‎‡2  ISNI|0000000022377125‏
996 ‎‡2  LC|n 2016029072‏
996 ‎‡2  LC|nb2007008665‏
996 ‎‡2  CAOONL|ncf10650789‏
996 ‎‡2  BIBSYS|10025519‏
996 ‎‡2  BIBSYS|90257244‏
996 ‎‡2  ISNI|0000000072171643‏
996 ‎‡2  LC|n 2003073788‏
996 ‎‡2  SUDOC|171609654‏
996 ‎‡2  BIBSYS|90070416‏
996 ‎‡2  J9U|987007333070405171‏
996 ‎‡2  BNF|15558708‏
996 ‎‡2  J9U|987007320220805171‏
996 ‎‡2  BIBSYS|90246272‏
996 ‎‡2  BNCHL|10000000000000000032075‏
996 ‎‡2  NII|DA02520963‏
996 ‎‡2  NTA|308327535‏
996 ‎‡2  BIBSYS|1102067‏
996 ‎‡2  BIBSYS|2035959‏
996 ‎‡2  PLWABN|9810647762205606‏
996 ‎‡2  LC|n 2013041318‏
996 ‎‡2  N6I|vtls002163744‏
996 ‎‡2  NUKAT|n 2017120346‏
996 ‎‡2  LC|n 2011052503‏
996 ‎‡2  ISNI|0000000031400649‏
996 ‎‡2  RERO|A027165212‏
996 ‎‡2  RERO|A003977159‏
996 ‎‡2  ISNI|0000000034122111‏
996 ‎‡2  SUDOC|085857564‏
996 ‎‡2  ISNI|0000000034716497‏
996 ‎‡2  DNB|121262873X‏
996 ‎‡2  SUDOC|157414353‏
996 ‎‡2  ISNI|0000000121191289‏
996 ‎‡2  LC|nb2011018674‏
996 ‎‡2  RERO|A005970576‏
996 ‎‡2  BIBSYS|90326029‏
996 ‎‡2  LC|no2014029241‏
996 ‎‡2  LC|n 77015342‏
996 ‎‡2  LC|n 94056586‏
996 ‎‡2  BIBSYS|90199448‏
996 ‎‡2  LC|n 95800645‏
996 ‎‡2  BIBSYS|90597657‏
996 ‎‡2  BIBSYS|12016357‏
996 ‎‡2  NUKAT|n 2006151459‏
996 ‎‡2  LC|n 78077272‏
996 ‎‡2  CAOONL|ncf10229640‏
996 ‎‡2  LC|n 2024002735‏
996 ‎‡2  J9U|987007376690305171‏
996 ‎‡2  BNC|981058508813106706‏
996 ‎‡2  LC|n 83052303‏
996 ‎‡2  NUKAT|n 2017027619‏
996 ‎‡2  LC|no2022083810‏
996 ‎‡2  NII|DA09218139‏
996 ‎‡2  DBC|87097969091725‏
996 ‎‡2  ISNI|0000000458767562‏
996 ‎‡2  NTA|395505771‏
996 ‎‡2  NKC|xx0189288‏
996 ‎‡2  ISNI|0000000455869037‏
996 ‎‡2  BIBSYS|90354675‏
996 ‎‡2  SUDOC|05801229X‏
996 ‎‡2  ISNI|0000000042415424‏
996 ‎‡2  LC|n 82031010‏
996 ‎‡2  NTA|422691291‏
996 ‎‡2  CAOONL|ncf10326089‏
996 ‎‡2  CAOONL|ncf10014625‏
996 ‎‡2  DNB|1073652750‏
996 ‎‡2  LC|n 00095123‏
997 ‎‡a  1947 0 lived 1115 0‏ ‎‡9  1‏
998 ‎‡a  Williams, Janet B.,‏ ‎‡2  SUDOC|10461935X‏ ‎‡3  suggested‏ ‎‡3  title: (0.83, 'structuredclinicalinterviewfordsm5clinicalversionanglais', 'structuredclinicalinterviewfordsm3r')‏
998 ‎‡a  Williams, Janet B. W.‏ ‎‡2  NSK|000254437‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.,‏ ‎‡2  NKC|xx0189288‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B.W.‏ ‎‡2  ISNI|000000008467917X‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.,‏ ‎‡2  ISNI|000000008467917X‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B.‏ ‎‡2  ISNI|000000008467917X‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.‏ ‎‡2  ISNI|000000008467917X‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W‏ ‎‡2  ISNI|000000008467917X‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.‏ ‎‡2  ISNI|000000008467917X‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B.W.‏ ‎‡2  W2Z|90206195‏ ‎‡3  title: (0.80, 'scid5105structuredclinicalinterviewfordsm5disorders', 'structuredclinicalinterviewfordsm3r')‏
998 ‎‡a  Williams, Janet B. W.‏ ‎‡2  DNB|1145566154‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.,‏ ‎‡2  LC|n 83157734‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.,‏ ‎‡2  J9U|987007422151605171‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.‏ ‎‡2  NUKAT|n 2018280655‏ ‎‡3  suggested‏ ‎‡3  viafid‏ ‎‡3  title: (0.82, 'usersguidetostructuredclinicalinterviewfordsm5', 'structuredclinicalinterviewfordsm3r')‏
998 ‎‡a  Williams, Janet B. W.‏ ‎‡2  NII|DA05008112‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B. W.,‏ ‎‡2  NDL|00963987‏ ‎‡3  suggested‏
998 ‎‡a  Williams, Janet B.W.‏ ‎‡2  BIBSYS|90206195‏ ‎‡3  title: (0.80, 'scid5105structuredclinicalinterviewfordsm5disorders', 'structuredclinicalinterviewfordsm3r')‏
998 ‎‡a  Williams, Janet B.W.,‏ ‎‡2  NTA|070293694‏ ‎‡3  suggested‏ ‎‡3  title: (0.79, 'structuredclinicalinterviewfordsm5disordersscid5105clinicianversion', 'structuredclinicalinterviewfordsm3r')‏